We are thrilled to announce that Professor Rob Griffin of the Department of Radiation Oncology has been honored with the J. Eugene Robinson Award for his outstanding contributions to the field of hyperthermic oncology. This prestigious award is presented annually to a distinguished investigator who has significantly advanced our understanding and application of hyperthermia in cancer treatment.
Hyperthermic oncology, a field pioneered by J. Eugene Robinson, involves the use of heat to enhance the effects of treatments like radiation and chemotherapy. Robinson, who first employed hyperthermia as an anti-cancer treatment in the late 1960s, dedicated 20 years to exploring its potential. His groundbreaking work set the foundations for today’s thermal therapies, focusing on critical aspects such as thermal dose and time-temperature relationships.
The J. Eugene Robinson Award rotates annually among three main disciplines within thermal medicine: physics, biology, and clinical/medicine. It recognizes those who have made exceptional strides in these areas, continuing Robinson’s legacy of innovation and dedication.
Professor Griffin’s work has been instrumental in developing new hyperthermic treatment strategies and technologies that have significantly improved patient outcomes. His research not only honors the tradition of innovation set forth by J. Eugene Robinson but also propels it into the future with cutting-edge advancements.
Please join us in congratulating Professor Rob Griffin on this remarkable achievement. His dedication to advancing cancer treatment through hyperthermic oncology exemplifies the spirit of innovation and excellence we value so highly in our department.